These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 32144191)
1. Insights into the improved macrolide inhibitory activity from the high-resolution cryo-EM structure of dirithromycin bound to the Pichkur EB; Paleskava A; Tereshchenkov AG; Kasatsky P; Komarova ES; Shiriaev DI; Bogdanov AA; Dontsova OA; Osterman IA; Sergiev PV; Polikanov YS; Myasnikov AG; Konevega AL RNA; 2020 Jun; 26(6):715-723. PubMed ID: 32144191 [TBL] [Abstract][Full Text] [Related]
2. Structure of Dirithromycin Bound to the Bacterial Ribosome Suggests New Ways for Rational Improvement of Macrolides. Khabibullina NF; Tereshchenkov AG; Komarova ES; Syroegin EA; Shiriaev DI; Paleskava A; Kartsev VG; Bogdanov AA; Konevega AL; Dontsova OA; Sergiev PV; Osterman IA; Polikanov YS Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30936109 [TBL] [Abstract][Full Text] [Related]
3. Drug sensing by the ribosome induces translational arrest via active site perturbation. Arenz S; Meydan S; Starosta AL; Berninghausen O; Beckmann R; Vázquez-Laslop N; Wilson DN Mol Cell; 2014 Nov; 56(3):446-452. PubMed ID: 25306253 [TBL] [Abstract][Full Text] [Related]
4. High-resolution crystal structures of ribosome-bound chloramphenicol and erythromycin provide the ultimate basis for their competition. Svetlov MS; Plessa E; Chen CW; Bougas A; Krokidis MG; Dinos GP; Polikanov YS RNA; 2019 May; 25(5):600-606. PubMed ID: 30733327 [TBL] [Abstract][Full Text] [Related]
5. Interplay between the ribosomal tunnel, nascent chain, and macrolides influences drug inhibition. Starosta AL; Karpenko VV; Shishkina AV; Mikolajka A; Sumbatyan NV; Schluenzen F; Korshunova GA; Bogdanov AA; Wilson DN Chem Biol; 2010 May; 17(5):504-14. PubMed ID: 20534348 [TBL] [Abstract][Full Text] [Related]
6. A long-distance rRNA base pair impacts the ability of macrolide antibiotics to kill bacteria. Svetlov MS; Cohen S; Alsuhebany N; Vázquez-Laslop N; Mankin AS Proc Natl Acad Sci U S A; 2020 Jan; 117(4):1971-1975. PubMed ID: 31932436 [TBL] [Abstract][Full Text] [Related]
7. Binding and action of CEM-101, a new fluoroketolide antibiotic that inhibits protein synthesis. Llano-Sotelo B; Dunkle J; Klepacki D; Zhang W; Fernandes P; Cate JH; Mankin AS Antimicrob Agents Chemother; 2010 Dec; 54(12):4961-70. PubMed ID: 20855725 [TBL] [Abstract][Full Text] [Related]
8. Structure of the mammalian antimicrobial peptide Bac7(1-16) bound within the exit tunnel of a bacterial ribosome. Seefeldt AC; Graf M; Pérébaskine N; Nguyen F; Arenz S; Mardirossian M; Scocchi M; Wilson DN; Innis CA Nucleic Acids Res; 2016 Mar; 44(5):2429-38. PubMed ID: 26792896 [TBL] [Abstract][Full Text] [Related]
9. Stepwise binding of tylosin and erythromycin to Escherichia coli ribosomes, characterized by kinetic and footprinting analysis. Petropoulos AD; Kouvela EC; Dinos GP; Kalpaxis DL J Biol Chem; 2008 Feb; 283(8):4756-65. PubMed ID: 18079110 [TBL] [Abstract][Full Text] [Related]
10. Context-specific action of macrolide antibiotics on the eukaryotic ribosome. Svetlov MS; Koller TO; Meydan S; Shankar V; Klepacki D; Polacek N; Guydosh NR; Vázquez-Laslop N; Wilson DN; Mankin AS Nat Commun; 2021 May; 12(1):2803. PubMed ID: 33990576 [TBL] [Abstract][Full Text] [Related]
11. Cryo-EM Structures Reveal Relocalization of MetAP in the Presence of Other Protein Biogenesis Factors at the Ribosomal Tunnel Exit. Bhakta S; Akbar S; Sengupta J J Mol Biol; 2019 Mar; 431(7):1426-1439. PubMed ID: 30753870 [TBL] [Abstract][Full Text] [Related]
12. Kinetics of drug-ribosome interactions defines the cidality of macrolide antibiotics. Svetlov MS; Vázquez-Laslop N; Mankin AS Proc Natl Acad Sci U S A; 2017 Dec; 114(52):13673-13678. PubMed ID: 29229833 [TBL] [Abstract][Full Text] [Related]
13. Critical 23S rRNA interactions for macrolide-dependent ribosome stalling on the ErmCL nascent peptide chain. Koch M; Willi J; Pradère U; Hall J; Polacek N Nucleic Acids Res; 2017 Jun; 45(11):6717-6728. PubMed ID: 28369621 [TBL] [Abstract][Full Text] [Related]
14. Structure of the E. coli ribosome-EF-Tu complex at <3 Å resolution by Cs-corrected cryo-EM. Fischer N; Neumann P; Konevega AL; Bock LV; Ficner R; Rodnina MV; Stark H Nature; 2015 Apr; 520(7548):567-70. PubMed ID: 25707802 [TBL] [Abstract][Full Text] [Related]
15. New drugs--reports of new drugs recently approved by the FDA. Dirithromycin. Shinkai I; Ohta Y Bioorg Med Chem; 1996 Apr; 4(4):521-2. PubMed ID: 8735838 [TBL] [Abstract][Full Text] [Related]
16. Conjugates of Desmycosin with Fragments of Antimicrobial Peptide Oncocin: Synthesis, Antibacterial Activity, Interaction with Ribosome. Khairullina ZZ; Makarov GI; Tereshchenkov AG; Buev VS; Lukianov DA; Polshakov VI; Tashlitsky VN; Osterman IA; Sumbatyan NV Biochemistry (Mosc); 2022 Sep; 87(9):871-889. PubMed ID: 36180983 [TBL] [Abstract][Full Text] [Related]
17. Sequence-dependent elongation dynamics on macrolide-bound ribosomes. Johansson M; Chen J; Tsai A; Kornberg G; Puglisi JD Cell Rep; 2014 Jun; 7(5):1534-1546. PubMed ID: 24836000 [TBL] [Abstract][Full Text] [Related]
18. Selective protein synthesis by ribosomes with a drug-obstructed exit tunnel. Kannan K; Vázquez-Laslop N; Mankin AS Cell; 2012 Oct; 151(3):508-20. PubMed ID: 23101624 [TBL] [Abstract][Full Text] [Related]
19. Macrolide-peptide conjugates as probes of the path of travel of the nascent peptides through the ribosome. Washington AZ; Benicewicz DB; Canzoneri JC; Fagan CE; Mwakwari SC; Maehigashi T; Dunham CM; Oyelere AK ACS Chem Biol; 2014 Nov; 9(11):2621-31. PubMed ID: 25198768 [TBL] [Abstract][Full Text] [Related]
20. A combined cryo-EM and molecular dynamics approach reveals the mechanism of ErmBL-mediated translation arrest. Arenz S; Bock LV; Graf M; Innis CA; Beckmann R; Grubmüller H; Vaiana AC; Wilson DN Nat Commun; 2016 Jul; 7():12026. PubMed ID: 27380950 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]